Raymond Anderson

Insider Reports History

Location
Wilmette, IL
Signature
/s/ Quan Vu, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raymond Anderson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Director Stock Options 2,924 02 Dec 2025 Direct

Insider Reports Filed by Raymond Anderson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNPR Monopar Therapeutics 02 Dec 2025 1 $0 4 Director 08 Dec 2025, 16:48
MNPR Monopar Therapeutics 04 Mar 2025 1 $0 4 Director 07 Mar 2025, 19:55
MNPR Monopar Therapeutics 31 Dec 2023 2 $0 4 Director 03 Jan 2024, 19:40
MNPR Monopar Therapeutics 30 Sep 2023 2 $0 4 Director 03 Oct 2023, 19:31
MNPR Monopar Therapeutics 30 Jun 2023 2 $0 4 Director 03 Jul 2023, 18:50
MNPR Monopar Therapeutics 31 Mar 2023 2 $0 4 Director 04 Apr 2023, 17:18
MNPR Monopar Therapeutics 01 Feb 2023 2 $0 4 Director 03 Feb 2023, 17:51
MNPR Monopar Therapeutics 31 Dec 2022 2 $0 4 Director 03 Jan 2023, 15:11
MNPR Monopar Therapeutics 30 Sep 2022 2 $0 4 Director 03 Oct 2022, 19:38
MNPR Monopar Therapeutics 30 Jun 2022 2 $0 4 Director 01 Jul 2022, 16:14
MNPR Monopar Therapeutics 31 Mar 2022 2 $0 4 Director 01 Apr 2022, 17:02
MNPR Monopar Therapeutics 02 Feb 2022 2 $0 4 Director 04 Feb 2022, 18:33
MNPR Monopar Therapeutics 31 Dec 2021 2 $0 4 Director 04 Jan 2022, 12:45
MNPR Monopar Therapeutics 30 Sep 2021 2 $0 4 Director 01 Oct 2021, 19:27
MNPR Monopar Therapeutics 30 Jun 2021 2 $0 4 Director 02 Jul 2021, 17:18